Recombinant Snaclec rhodocytin subunit alpha protein (His tag)

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Snaclec rhodocytin subunit alpha also called aggretin or rhodocytin-α functions as part of a snake venom protein complex found in Calloselasma rhodostoma venom. It has a molecular mass of around 16 kDa and is known for its role in platelet activation. Rhodocytin-α is expressed in the venom glands of Calloselasma rhodostoma playing a role in the snake's defense and hunting strategies. The protein binds and interacts with specific receptors on platelets contributing to the process of platelet aggregation.

Biological function summary

Rhodocytin-α contributes to the initiation of platelet aggregation by interacting with the glycoprotein VI (GPVI) receptor on the surface of platelets. It forms part of the larger rhodocytin complex with other subunits that synergize to enhance its binding and aggregative properties. Through its action on platelets it can influence thrombus formation and serve as a model for understanding various aspects of hemostasis and thrombosis. This makes it an intriguing subject for research into blood clotting mechanisms.

Pathways

Rhodocytin-α participates in the platelet activation pathway modulating thrombus formation involving the GPVI signaling cascade. Upon binding platelets rhodocytin-α triggers a cascade that includes the activation of spleen tyrosine kinase (Syk) and various downstream effectors such as phospholipase C gamma 2 (PLCγ2). This cascade causes the release of secondary messengers resulting in platelet shape change and aggregation. The interaction between rhodocytin-α and these proteins highlights its importance in regulating platelet function and clot stability.

Research links rhodocytin-α to hemostatic disorders providing insights into conditions like thrombocytopenia where platelet function is impaired. Its action with GPVI and associated signaling components offers clues about abnormal platelet activation in these disorders. Additionally studies have reported that variations in GPVI expression or function may influence individual susceptibility to thrombotic diseases presenting potential targets for therapeutic intervention. Understanding rhodocytin-α's interactions helps unravel the complexities of platelet-related diseases and their management.